WallStreetZenWallStreetZen

NASDAQ: MYMD
Mymd Pharmaceuticals Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

MYMD past revenue growth

How has MYMD's revenue growth performed historically?
Company
N/A
Industry
144.63%
Market
17.55%
MYMD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
MYMD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

MYMD earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$8.2M
Current Profit Margin
0%

MYMD Return on Equity

Current Company
-63.6%
Current Industry
-63.5%
Current Market
188%
MYMD's Return on Equity (-63.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when MYMD announces earnings.

MYMD Return on Assets

Current Company
-35.2%
Current Industry
2.9%
MYMD is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

MYMD Return on Capital Employed

Current Company
-31.07%
Current Industry
19.5%
MYMD's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MYMD vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
MYMD$0.00-$4.00M-$8.22M-100.00%N/A
IBIO$50.00k-$25.95M-$27.28M-43.46%N/A
PCSA$0.00-$11.04M-$11.12MN/AN/A
PTIX$0.00-$4.86M-$5.00MN/AN/A
SCPX$6.99M-$36.93M-$45.22M+3.84%N/A
View Top Biotech Stocks

MYMD earnings dates

Next earnings date
May 13, 2024

Mymd Pharmaceuticals Earnings & Revenue FAQ

What were MYMD's earnings last quarter?

On Invalid Date, Mymd Pharmaceuticals (NASDAQ: MYMD) reported Q4 2023 earnings per share (EPS) of -$2.93, up 6.93% year over year. Total Mymd Pharmaceuticals earnings for the quarter were -$4.89 million. In the same quarter last year, Mymd Pharmaceuticals's earnings per share (EPS) was -$2.74.

If you're new to stock investing, here's how to buy Mymd Pharmaceuticals stock.

What was MYMD's earnings growth in the past year?

As of Q2 2024, Mymd Pharmaceuticals's earnings has grown year over year. Mymd Pharmaceuticals's earnings in the past year totalled -$8.22 million.

What is MYMD's earnings date?

Mymd Pharmaceuticals's earnings date is Invalid Date. Add MYMD to your watchlist to be reminded of MYMD's next earnings announcement.

What was MYMD's revenue last quarter?

On Invalid Date, Mymd Pharmaceuticals (NASDAQ: MYMD) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Mymd Pharmaceuticals's revenue was $0.00.

What was MYMD's revenue growth in the past year?

As of Q2 2024, Mymd Pharmaceuticals's revenue has grown null year over year. Mymd Pharmaceuticals's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.